ArticlePloS one2017

Quantification of HBsAg to predict low levels and seroclearance in HBeAg-negative patients receiving nucleos(t)ide analogues.

Teresa Broquetas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.